Compare JBTM & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBTM | TFX |
|---|---|---|
| Founded | 1994 | 1943 |
| Country | United States | United States |
| Employees | 11500 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.8B |
| IPO Year | N/A | 1994 |
| Metric | JBTM | TFX |
|---|---|---|
| Price | $136.29 | $132.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $180.00 | $138.75 |
| AVG Volume (30 Days) | ★ 452.3K | 377.3K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | 0.34% | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $8.10 | $15.97 |
| Revenue Next Year | $4.68 | $5.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $113.67 | $100.18 |
| 52 Week High | $170.19 | $139.67 |
| Indicator | JBTM | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 51.07 |
| Support Level | $121.63 | $126.25 |
| Resistance Level | $137.11 | $137.19 |
| Average True Range (ATR) | 4.47 | 4.00 |
| MACD | -0.77 | -0.17 |
| Stochastic Oscillator | 33.11 | 40.10 |
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.